GCANPharmaceutical PreparationsFiscal year ends December 31Also trades as GCAND
TRAFALGAR INTERNATIONAL, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.14+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $1.13M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$1.14 (+75,900%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $1.13M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- $879.66K
- EPS, diluted
- $0.00
- Book value per share
- -$0.01
- Diluted shares
- 1M
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$136.15K
Net income
$879.66K
EPS, diluted
–
Reported periodTrailing twelve months